Sanjeev Bhatt in Budget Quote Merrill Life Sciences...
The medical devices sector globally has experienced significant growth, becoming essential for modern healthcare. India's government initiatives, including the Production Linked Incentive (PLI) scheme, have made the country a global hub for affordable medical technology. As the central budget approaches, continued support in R&D and industry incentives is expected to sustain this progress, driving innovation and self-reliance in MedTech manufacturing.
New Delhi: The global medical devices sector has witnessed significant growth, becoming a cornerstone of modern healthcare by improving patient outcomes and opportunities. In India, the first quarter of the 21st century marked a transformation, positioning the country as a global hub for high-quality, affordable medical technology.
This progress has been strongly supported by the Indian government's visionary initiatives, such as the Production Linked Incentive (PLI) scheme and a strong focus on healthcare infrastructure. These actions have encouraged innovation, investment, and self-reliance in MedTech manufacturing. As the central budget approaches, we are looking forward to continued support in R&D, exports, and industry-based incentives to sustain this momentum.
At Merrill, we are pleased to contribute to India’s MedTech development by providing world-class, life-changing solutions. We are committed to advancing India’s position as a leader in global healthcare innovations for a healthier future.
For more insights on business and industry developments, visit Vaartha Business.
What's Your Reaction?
